Navarese EP, Robinson JG, Kowalewski M et al. Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering: A Systematic Review and Meta-analysis. JAMA 2018; 319:1566-1579
De Boer SPM, Baran Y, Garcia-Garcia HM, et al. The European Collaborative Project on Inflammation and Vascular Wall Remodeling in Atherosclerosis – Intravascular Ultrasound (ATHEROREMO-IVUS) study. Eurointervention 2018;14:194-203.
Sharma A, Hijazi Z, MD, Andersson U, et al. The Use of Biomarkers to Predict Specific Causes of Death in Patients with Atrial Fibrillation: Insights from the ARISTOTLE Trial. Circulation 2018;doi: 10.1161/CIRCULATIONAHA.118.034125 [Epub ahead …
Selak V et al. Annual Risk of Major Bleeding Among Persons Without Cardiovascular Disease Not Receiving Antiplatelet Therapy. JAMA. 2018;319(24):2507-2520.
La decisione di iniziare la terapia con aspirina per la prevenzione primaria delle malattie cardiovascolari …
Jorge A. Wong, David Conen, Isabelle C. Van Gelder, William F. McIntyre, Harry J. Crijns, Jia Wang, Michael R. Gold, Stefan H. Hohnloser, C.P. Lau, Alessandro Capucci, Gianluca Botto, Gerian Grönefeld, Carsten W. …
I risultati dello studio randomizzato “Tenecteplase Versus Alteplase Before Endovascular Therapy for Ischemic Stroke” (EXTEND-IA TNK)1 hanno messo in evidenza che utilizzare il tenecteplase somministrato entro 4,5 ore dall’esordio dei sintomi …
Navarese EP, Robinson JG, Kowalewski M et al. Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering: A Systematic Review and Meta-analysis. JAMA 2018; 319:1566-1579
Hart RG, et al. Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source. N Engl J Med. 2018 May 16. doi: 10.1056/NEJMoa1802686. [Epub ahead of print] PubMed PMID: 29766772.